Internal Medicine, Gastroenterology · McAllen, TX
NPI
1588866370
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
801 E Nolana Ave, Suite 4
McAllen, TX, 78504
Phone (956) 686-2626
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
2,054 services
Medicare patients, 2024
324
Average age 74
Drug cost, 2024
$2.4M
3,802 prescriptions
Company payments, 2025
$914
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Valeska Balderas was code 88305 (surgical pathology examination), 179 times for 70 patients. In total Valeska Balderas billed 2,054 services in 49 codes, and Medicare paid $94K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 179 | 70 | $28.17 | $5,042 |
| 99214 Office E&M - Established | Office | 152 | 110 | $91.33 | $14K |
| 99213 Office E&M - Established | Office | 111 | 91 | $62.83 | $6,975 |
| 88313 Surgical Pathology Examination | Office | 111 | 40 | $57.00 | $6,328 |
| 88312 Surgical Pathology Examination | Office | 89 | 37 | $69.53 | $6,188 |
| 99203 Office E&M - New | Office | 63 | 63 | $81.65 | $5,144 |
| 91200 Standard X-ray | Office | 50 | 40 | $24.49 | $1,225 |
| 43239 Upper GI Endoscopy | Facility | 48 | 48 | $84.60 | $4,061 |
| 99204 Office E&M - New | Office | 46 | 46 | $115.37 | $5,307 |
| 99222 Hospital E&M - Initial | Facility | 45 | 45 | $95.06 | $4,278 |
| 45380 Lower GI Endoscopy - Other | Facility | 35 | 35 | $138.65 | $4,853 |
| 45385 Colonoscopy - Lesion Removal | Facility | 26 | 26 | $214.14 | $5,568 |
| 99233 Hospital E&M - Subsequent | Facility | 22 | 17 | $85.71 | $1,886 |
| 93975 Duplex Scan - Extremity Arteries | Office | 19 | 15 | $211.95 | $4,027 |
| 76705 Ultrasound - Abdomen and Pelvis | Office | 17 | 14 | $62.23 | $1,058 |
By year: 2022 $130K for 2,802 services; 2023 $125K for 2,721 services; 2024 $94K for 2,054 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 179 | 70 | $28.17 | $5,042 |
| 88313 Surgical Pathology Examination | 111 | 40 | $57.00 | $6,328 |
| 88312 Surgical Pathology Examination | 89 | 37 | $69.53 | $6,188 |
Medicare prescription drug claims, 2024
In 2024, the drug Valeska Balderas prescribed most often to Medicare patients was Famotidine, with 791 prescriptions and refills. In total Valeska Balderas wrote 3,802 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 791 | 1,791 | 367 | $16K |
| Pantoprazole Sodium Generic | 511 | 1,058 | 230 | $5,528 |
| Omeprazole Generic | 286 | 542 | 139 | $3,301 |
| Linzess Linaclotide | 236 | 459 | 96 | $234K |
| Sucralfate Generic | 188 | 270 | 78 | $13K |
| Dicyclomine Hcl Generic | 179 | 240 | 74 | $5,190 |
| Lactulose Generic | 164 | 204 | 78 | $9,071 |
| Constulose Lactulose | 131 | 156 | 68 | $5,838 |
| Ursodiol Generic | 115 | 220 | 37 | $16K |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 90 | 90 | 88 | $1,372 |
| Xifaxan Rifaximin | 88 | 88 | 20 | $278K |
| Trulance Plecanatide | 87 | 141 | 29 | $76K |
| Enulose Lactulose | 73 | 94 | 46 | $4,657 |
| Metoclopramide Hcl Generic | 61 | 82 | 26 | $519 |
| Creon Lipase/Protease/Amylase | 51 | 65 | 17 | $151K |
Brand drugs: 839 claims; generic drugs: 2,963 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Valeska Balderas $914 ($914 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $267.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $267 |
| Ardelyx, Inc. ARDX | 8 | $176 |
| Gilead Sciences, Inc. GILD | 7 | $166 |
| Janssen Biotech, Inc. JNJ | 1 | $113 |
| Pfizer Inc. PFE | 2 | $51.09 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $32.78 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $30.47 |
| Aimmune Therapeutics, Inc. | 1 | $15.77 |
| Lilly USA, LLC LLY | 1 | $15.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.